Skip to content
healthcare.dev

Topcare Mucus ER

NDC 76162-409, guaifenesin, tablet, multilayer, extended release, from Topco Associates LLC.

Product NDC
76162-409
Status
Listed
Labeler
Topco Associates LLC
Dosage form
TABLET, MULTILAYER, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA078912
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76162-409 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN1200 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
76162-409-01761620409014 BLISTER PACK in 1 CARTON (76162-409-01) / 7 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BLISTER PACK
76162-409-74761620409742 BLISTER PACK in 1 CARTON (76162-409-74) / 7 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 76162-409 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76162-409 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76162-409. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.